No headlines found.
Pulsenmore Announces Full Year 2025 Financial Results and Webcast
PRNewswire (Mon, 30-Mar 8:29 AM ET)
Pulsenmore Announces Full Year 2025 Earnings Conference Call
PRNewswire (Wed, 25-Mar 8:00 AM ET)
Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.
Pulsenmore Ltd. - trades on the NASDAQ stock market under the symbol PLSM.
As of May 13, 2026, PLSM stock price climbed to $5.58 with 234,564 million shares trading.
PLSM has a market cap of $36.29 million. This is considered a Sub-Micro Cap stock.
PLSM support price is $3.30 and resistance is $3.96 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PLSM shares will trade within this expected range on the day.